Armata Pharmaceuticals, Inc.
AMEX: ARMP0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- New York Stock Exchange American
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Deborah L. Birx
- Employees
- 60
- Headquarters
- Marina del Rey, United States
- IPO year
- 1994
- Market cap
- $259.9M
- Website
- https://www.armatapharma.com
Loading ARMP…
Loading profile data…Frequently asked questions about ARMP
What does Armata Pharmaceuticals, Inc. (ARMP) do?
Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology enterprise with a global focus on creating specialized bacteriophage therapeutics. Its primary objective is to tackle infections that have developed resistance to standard antibiotics. The company's innovative treatments are developed utilizing its exclusive bacteriophage-ba...
Where does ARMP trade?
Armata Pharmaceuticals, Inc. (ARMP) trades on the New York Stock Exchange American.
What sector is ARMP in?
Armata Pharmaceuticals, Inc. (ARMP) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Armata Pharmaceuticals, Inc.?
Deborah L. Birx is the chief executive officer of Armata Pharmaceuticals, Inc. (ARMP).
Where is Armata Pharmaceuticals, Inc. headquartered?
Armata Pharmaceuticals, Inc. is headquartered in United States.
Does ARMP pay a dividend?
Armata Pharmaceuticals, Inc. (ARMP) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ARMP go public?
Armata Pharmaceuticals, Inc. (ARMP) completed its initial public offering in 1994.